AMAndrew D. Michaels

Andrew D. Michaels

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Andrew D. Michaels has a total of 240 co-authors. Here are the top co-authors by number of shared publications:

  • Elyse Foster

    Division of Cardiology, Department of Medicine, University of California San Francisco, San Francisco, California

    4 shared publications
  • Mark V. Jordan

    Department of Medicine, University of California, San Francisco

    4 shared publications
  • Sanjiv J. Shah

    Division of Cardiology, Department of Medicine, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA

    4 shared publications
  • Barry H. McKeown

    Division of Cardiology, University of California, San Francisco

    3 shared publications
  • Gregory M. Marcus

    Division of Cardiology, University of California, San Francisco

    3 shared publications
  • Ivor L. Gerber

    Division of Cardiology, University of California, San Francisco

    3 shared publications

Latest Publications

    • 1 March 2012
      • Vol. 125  (6) , 1057-62

    Defective T wave combined with incomplete right bundle branch block: a new electrocardiographic index for diagnosing atrial septal defect.

    by Mu-Xuan Wang, Gui-Fu Wu, Jing-Li Gu, Li Li, Kun Lu, Da Yang, Long Chen, Xi Zhang, Fu-Tian Luo, Andrew D Michaels, et al.

    Incomplete right bundle branch block (ICRBBB) is commonly associated with atrial septal defect (ASD), but lacks sufficient diagnostic test characteristics. An abnormal T wave is also often observed in ASD, with horizontal or inverted displacement of the proximal T wave limb in the right precordial leads, termed "defective T wave" (DTW). We examined the diagnostic test characteristics of combining ICRBBB with DTW as a new index to diagnose ASD. A total of 132 consecutive patients with ASD and 132 cases of age/gender-matched controls without ASD were enrolled. Sensitivities of DTW, ICRBBB, and both were 87.1% - 87.9%. Specificities were 97.0%, 96.2%, and 100%, respectively. Positive predictive values were 1.3%, 1.1%, and 100.0% respectively, while negative predictive values were 99.9% for each. Combining ICRBBB with DTW in electrocardiogram (ECG) as a new index significantly increased the specificity and positive predictive values while maintaining a high sensitivity in diagnosing ASD.


  • Open Access

    Noninvasive Prediction of Left Ventricular Systolic Dysfunction in Patients With Clinically Suspected Heart Failure Using Acoustic Cardiography

    by Douglas L. Kosmicki, Sean P. Collins, Michael C. Kontos, Michel Zuber, Peter Kipfer, Christine Attenhofer Jost, Andrew D. Michaels

    The signs and symptoms of systolic heart failure are frequently insensitive and nonspecific, making an accurate bedside diagnosis of left ventricular systolic dysfunction (LVSD) challenging. B‐type natriuretic peptide (BNP) is often used, but is not diagnostically useful when in the indeterminate range. The authors investigated the diagnostic test characteristics of acoustic cardiographic parameters to identify patients with LVSD. Four hundred thirty‐three patients with contemporaneous measurements of computerized acoustic cardiography, BNP, and echocardiography were included. The acoustic cardiographic model outperformed BNP alone at detecting reduced left ventricular ejection fraction (C statistic, 0.88 vs 0.67; P<.0001). The acoustic model with BNP did not perform better than the acoustic model alone (P=.14). Within the indeterminate BNP range, the acoustic model outperformed BNP (C statistic, 0.89 vs 0.64; P<.0001). Noninvasive computerized acoustic cardiography predicted LVSD in a diverse population. This acoustic cardiographic model outperformed BNP alone for predicting LVSD. Congest Heart Fail. 2010;16:249–253.


  • Experienced Clinicians Improve Detection of Third and Fourth Heart Sounds by Viewing Acoustic Cardiography

    by Andrew D. Michaels, Farman U. Khan, Brian Moyers

    Background Clinical assessment of diastolic heart sounds is challenging. Hypothesis We sought to examine whether visual inspection of acoustic cardiographic tracings augments the accuracy of medical students' and physicians' detection of third and fourth heart sounds (S3, S4) compared to auscultation alone. Methods A total of 90 adults referred for left heart catheterization underwent digital precordial heart sound recordings by computerized acoustic cardiography. Two blinded, experienced readers using a consensus method determined the presence of the S3/S4 on each file. There were 35 subjects from the following 5 groups participating in this study from 1 teaching institution: first‐year medical students (n = 5), fourth‐year medical students (n = 5), interns (n = 5), medicine residents (n = 5), cardiology fellows (n = 5), and attendings (n = 10). Using a computer module, each subject listened to the heart sounds alone and documented whether an S3/S4 was present. Next, subjects listened to each recording in random order while viewing phonocardiographic tracings, and recorded S3/S4 presence. Results An S3 was present in 21 patients (23%) and an S4 in 31 patients (34%) by consensus overread in 90 recordings. Baseline accuracy for auscultation of S3/S4 did not change with level of experience. While viewing the acoustic cardiogram, first‐year medical students had minimal improvement in S3 (2%) and S4 (11%) accuracy. More experienced subjects improved S3 accuracy by 8% to 18% and S4 by 15% to 32% (P < .05). Accuracy was superior for S3 compared to S4 in all ausculatory groups. Conclusions While listening to heart sound recordings, viewing acoustic cardiography increased subjects' accuracy in detecting diastolic heart sounds, particularly among more experienced subjects. There was greater improvement for S4 compared to S3 detection. Copyright


  • Lead Authors and Contributors

    by Ivor J. Benjamin, Sara G. Tariq, Susan S. Beland, David Bull, Mohamed H. Hamdan, Dean Y. Li, Sheldon E. Litwin, Andrew D. Michaels, Jack H. Morshedzadeh, Josef Stehlik, et al.

  • Open Access

    Endomyocardial Biopsy of Right Atrial Angiosarcoma Guided by Intracardiac Echocardiography

    by Suman S. Kuppahally, Sheldon E. Litwin, Andrew D. Michaels

    We report a case of a 22-year-old female who presented with pericardial effusion and cardiac tamponade. She was diagnosed with a right atrial mass by computed tomography and was referred to our institution for biopsy of this mass. Transcatheter biopsy was performed with intracardiac echocardiography (ICE) guidance, avoiding the need for transesophageal echocardiography or surgery to obtain the biopsy. ICE for transcatheter biopsy of an intracardiac mass is an attractive modality which provides precise localization of the cardiac structures.


  • Population-based Assessment of Familial Inheritance and Neurologic Comorbidities among Patients with an Isolated Atrial Septal Defect

    by Matthew H. Steenblik, Geraldine P. Mineau, Richard Pimentel, Andrew D. Michaels

    Background. Interatrial shunts, caused by either atrial septal defect (ASD) or patent foramen ovale, have been reported to have a familial association. We sought to examine the familial risk of isolated interatrial shunt and explore associated comorbidities of stroke, transient ischemic attack (TIA), and migraine using a population database. Methods. The Utah Population Database is linked to inpatient and outpatient records from the University of Utah Health Science Center. Patients with an interatrial shunt were identified, and those with any other form of congenital heart disease or an inheritable syndrome associated with ASD were excluded. Of the 9452 individuals diagnosed with isolated interatrial shunt, 6179 (65%) had sufficient familial and follow-up data for analysis. Five age/gender matched controls were randomly selected per case. Cases and their relatives were compared with controls to assess the relative risk for each comorbid condition. Results. Relatives of interatrial shunt cases had an increased risk for interatrial shunt: siblings relative risk (RR) 6.98 (95% confidence interval [CI] 5.75–8.48; P < 1.0 × 10−16), first-degree RR 5.64 (95% CI 4.76–6.68; P < 1.0 × 10−16), and second-degree RR 1.75 (95% CI 1.32–2.32; P= 0.0001). Patients with interatrial shunt were more likely to have a comorbid condition compared with controls (RR 21.3, 95% CI 17.1–26.5; P < 1.0 × 10−16). First-degree relatives of cases had an increased risk of TIA (RR 1.70, 95% CI 1.18–2.45; P= 0.0045), but no increase risk of stroke or migraine compared with controls. Conclusions. There is a strong familial inheritance pattern for isolated interatrial shunt, with significantly higher risk of interatrial shunt among affected patients' siblings, first-, and second-degree relatives. Relatives of affected individuals also had a higher risk of TIA, a trend toward an increased risk for stroke, but no increased risk of migraine headache.


  • Adjusting for Clinical Covariates Improves the Ability of B-Type Natriuretic Peptide to Distinguish Cardiac from Non-Cardiac Dyspnoea: A Sub-Study of HEARD-IT

    by R. Kevin Rogers, Josef Stehlik, Gregory J. Stoddard, Thomas Greene, Sean P. Collins, W. Frank Peacock, Alan D. Maisel, Paul Clopton, Andrew D. Michaels

    Aims: We sought to create a model that adjusts B-type natriuretic peptide (BNP) for specific covariates to better distinguish cardiac from non-cardiac dyspnoea. Methods and results: HEARD-IT was a multicentre, prospective study of the diagnostic utility of acoustic cardiography in the emergency department. Dyspnoeic patients more than 40 years were eligible. Two cardiologists independently adjudicated the HF outcome. Using logistic regression, a model adjusting BNP for pertinent covariates was developed (n = 740). The mean age was 66 ± 13 years. Age, gender, ethnicity, body mass index, blood urea nitrogen, and creatinine affected BNP levels independently of HF. The model adjusting BNP for these covariates improved the area under receiver operator characteristic curve for HF compared with BNP alone (0.948, 95% CI 0.934–0.963 vs. 0.937, 95% CI 0.920–0.954; P = 0.004). Net reclassification improvement, a novel metric of model performance, was 3.5% for those without HF (P = 0.05) compared with conventional, unadjusted BNP cut-offs. Thirteen of 116 (11%) patients without HF, but with unadjusted BNP values ≥100 pg/mL, were correctly reclassified as not having HF with the adjusted BNP model. Conclusion: Adjusting BNP for important covariates may improve its ability to distinguish cardiac from non-cardiac dyspnoea.


  • Unusual Presentation of Nickel Allergy Requiring Explantation of an Amplatzer Atrial Septal Occluder Device

    by David G. Rabkin, Kevin J. Whitehead, Andrew D. Michaels, Douglas L. Powell, S.V. Karwande

    Systemic allergic reaction to a percutaneous patent foramen ovale (PFO) occlusion device is a rare event with only scattered reports in the literature. Serious allergic reactions to these devices have a poorly defined incidence, presentation, and natural history. We present a woman with a previously unknown nickel allergy who developed severe chest pain beginning the morning after percutaneous device closure of the PFO. Despite multiple visits to her cardiologists and primary care physicians, the cause of her chest pain remained unclear. After seeking a second opinion at our medical center, skin testing showed a severe reaction to nickel. These symptoms were refractory to treatment until device explantation 18 mo later. This case highlights the importance of recognizing nickel allergy as a cause of chest pain following implantation of certain types of devices used for closure of PFOs and other heart defects. Copyright


  • Interatrial shunt closure devices in patients with nickel allergy

    by Bhavananda T. Reddy, Jeetendra B. Patel, Douglas L. Powell, Andrew D. Michaels

    We assessed outcomes in nickel allergic patients treated with percutaneous interatrial shunt device closure with the Helex device. Nickel toxicity has been well described in patients undergoing interatrial shunt closure with the Amplatzer device, which has a nitinol design. There have been no reports using Helex in nickel allergic patients. Ninety‐five consecutive patients underwent percutaneous interatrial shunt closure at a single US center by one operator. In those with possible nickel allergy, patch testing with the North American Contact Dermatitis Group standard series and a metal series was performed. The mean age was 48 ± 16 years (range 18‐81), 48% were male, 21 (22%) had atrial septal defect, and 74 (78%) had patent foramen ovale. Six patients had a positive skin test to nickel and underwent successful closure with Helex. Of the remaining 89 patients, 88 were closed with Amplatzer and one with Helex. All procedures were successful with no deaths, myocardial infarctions, strokes, or systemic emboli at six‐month followup. None of the Helex patients developed an allergic reaction, significant chest pain, or arrhythmia. Of those without pre‐procedural known nickel allergy, 12% had palpitations, 5% had atrial fibrillation, and 13% had chest pain. When compared with a published report that 89% of nickel‐allergic patients developing an allergic reaction to the Amplatzer or Premere device, Helex appeared far safer in nickel allergic patients (P < 0.001). In patients with nickel allergy, percutaneous interatrial shunt device closure with Helex device is safe, and is not associated with allergy to nickel.